L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia.
Overview & Synopsis
Open access biomedical research article published in Schizophr Bull Open.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia. |
|---|---|
| Author / Organization | Ponomareva OY, Redman B, Sayer MA, Wehring HJ, Vyas G, Richardson CM, Gold JM, Gorelick DA, Cihakova D, Talor MV, Hoag SW, Buchanan RW, Wang J, Chen S, Liu F, Wang JB, Kelly DL |
| Subject & Discipline | Schizophr Bull Open |
| Categories | Medicine & Health |
| Publication Year | 2020 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-118779 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |